Financial Services

CNO Financial Group, Inc. (CNO)

$3.8B
Market Cap
17.4
P/E Ratio
0.85
Beta
1.72%
Dividend Yield
Piotroski 5/9Altman Z 0.3 DistressROIC−WACC -5.9%

Quantitative Summary

Deterministic

CNO trades at 17.4x earnings, roughly in line with its sector average of 19.2x. Financial health is average: Piotroski 5/9, Altman Z 0.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of CNO Financial Group reveal a capital structure under significant strain, characterized by an ROIC-WACC spread of -5.9%, indicating that the firm is currently destroying value relative to its cost of equity. Despite this negative economic moat, reported earnings per share are buoyed primarily by extreme financial leverage rather than operational efficiency; the DuPont decomposition shows an Equity Multiplier of 14.70x driving a modest ROE of 8.7%, while net margins remain thin at 5.1% and asset turnover is low at 0.12x. This reliance on debt amplifies solvency risks, as evidenced by a distressively low Altman Z-Score of 0.3, which flags potential bankruptcy territory, even though the Piotroski F-Score of 5/9 suggests moderate financial strength in terms of profitability and leverage trends over time.

Valuation metrics present a mixed picture where current multiples appear compressed relative to historical norms but remain elevated compared to sector peers on an absolute basis if growth expectations are low. The stock trades at a P/E ratio of 17.4x, sitting below the sector average of 18.9x, yet this discount may reflect market skepticism regarding future cash flow generation given the stagnant revenue growth of just 0.9% year-over-year and the widening gap between returns generated and capital costs. Without evidence of margin expansion or improved asset utilization to offset the high leverage, the current multiple implies a pricing environment that assumes limited upside potential until operational efficiency improves significantly.

Risk factors are heavily weighted toward solvency concerns rather than growth prospects, underscored by the critical Altman Z-Score and substantial insider activity showing $10,199,724 in net selling over the last 90 days. These signals suggest that management and major shareholders may be concerned about liquidity pressures or valuation levels amidst a fragile balance sheet. The combination of negative spread economics, high leverage-driven returns, and active insider divestment creates an asymmetric risk profile where downside protection relies on operational turnaround rather than multiple expansion or revenue acceleration.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Valuation Context

17.4x
CNO P/E
19.2x
Sector Avg
-9%
vs Sector

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
0.3
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

5.1%
Net Margin
1.1%
ROIC
6.9%
WACC
ROIC − WACC Spread: -5.9%— Negative spread.
+0.9%
Revenue Growth (YoY)
-45.5%
Earnings Growth (YoY)

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

5.1%
Net Profit Margin
NI ÷ Revenue
×
0.12x
Asset Turnover
Revenue ÷ Assets
×
14.70x
Equity Multiplier
Assets ÷ Equity
=
8.7%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

13.70x
Debt / Equity
2.3x
Interest Coverage
3.7x
Net Debt / EBITDA
842.8M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$10M
Net Selling
0
Buy Transactions
6
Sale Transactions
2026-03-20GOLDBERG SCOTT L.Sold 2/8 qtrsGrant$465,847
2026-03-20GOLDBERG SCOTT L.Sold 2/8 qtrsSale$879,424
2026-02-18ZIMPFER MATTHEW JSold 2/8 qtrsGrant$1M
2026-02-18BHOJWANI GARY C.Sold 5/8 qtrsSale$4M
2026-02-18ZIMPFER MATTHEW JSold 2/8 qtrsSale$2M

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✗ Miss
Est: $0.79
Act: $0.79
-0.4%
Q3
✓ Beat
Est: $0.85
Act: $0.87
+1.8%
Q2
✓ Beat
Est: $0.92
Act: $1.29
+40.2%
Q1
✓ Beat
Est: $1.21
Act: $1.47
+21.9%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

8.2
Forward P/E
PEG Ratio
1.43
Price/Book
637352
Avg Volume
$44.86
52W High
$34.63
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$190M
Tracked Passive Exposure
8
ETFs Holding CNO
0.05%
Avg Weight in ETFs
$353B
Total ETF AUM

When investors buy or sell ETFs like KIE or MDYV, the fund manager is mechanically forced to buy or sell CNO shares regardless of CNO Financial Group, Inc.'s individual fundamentals. We estimate $190M of passive capital is structurally linked to CNO through 8 tracked ETFs. Passive flows have a limited but growing influence on CNO's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in CNO Financial Group, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

CNO Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
CNOEpicenterVIGETFVYMETFVBRETFUNMHigh RiskRGAHigh RiskFNFHigh RiskOSCRUnknownRNRHigh Risk
CNO Price Drop (%)0

If CNO Financial Group, Inc. (CNO) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies UNUM GROUP (UNM) as the most exposed collateral stock, sharing 3 ETFs with CNO. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 11 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

CNO Ownership Dynamics

Ticker
CNO

Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-0649$45.52$2,230.48
2026-04-221,077$43.61$46,967.97
2026-04-082,160$41.70$90,072
2026-03-2510,269$40.63$417,229.47
2026-03-0674$42.15$3,119.1
2026-03-0574$42.58$3,150.92
2026-02-1838$43.12$1,638.56
2026-02-042$42.31$84.62
2026-01-282,825$41.02$115,881.5
2025-12-0932$39.96$1,278.72
2025-11-2887$41.18$3,582.66
2025-11-2687$41.18$3,582.66
2025-11-2587$40.83$3,552.21
2025-11-247$40.45$283.15
2025-11-217$39.77$278.39
2025-11-207$39.67$277.69
2025-11-0642$40.33$1,693.86
2025-11-03447$40.02$17,888.94
2025-10-3123$39.91$917.93
2025-10-1564$40.07$2,564.48

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare CNO to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.